Europe - Germany • Industry focus
A&O Shearman
We only have limited information for this firm. Consider the following firms which have provided more information:
A&O Shearman follows an interdisciplinary and cross-border approach and advises a diverse client base consisting of pharmaceutical and biotechnology companies, medical technology and diagnostics providers as well as investors and financial services providers. Practice head Alexander Veith is experienced in transaction support; he is supported by counsel Eda Zhuleku, who is well versed pan-European regulatory matters. The latter include the advice on cloud-based digital healthcare platforms in medicine and telemedicine and on healthcare apps as well as reimbursement issues pertaining to medicines. Further competencies are assisting new companies with market entry in the in-vitro diagnostics area as well as supporting health incurance companies in contract-related matters; clients are also represented in patent disputes.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Very well managed team. Quick processing of inquiries at the highest professional level.'
- 'Very good collaboration with Eda Zhuleku. She works very quickly and very professionally and always offers very good, practical solutions.'
Abbreviated data is displayed for this firm.
Key clients
- Kyowa Kirin International (KKI)
- Novo Nordisk A/S
Abbreviated data is displayed for this firm.
Work highlights
- Advising Kyowa Kirin International on its joint venture collaboration with Grünenthal regarding KKI's established drug portfolio.
- Advising Bayer AG on the sale of its men's health product Nebido™ (testosterone undecanoate) to Grünenthal. The transaction volume totals up to €500 million.
Abbreviated data is displayed for this firm.